Risk factors for blood transfusion in traumatic and postpartum hemorrhage patients: Analysis of the CRASH-2 and WOMAN trials.

David A KolinHaleema Shakur-StillAdenike BelloRizwana ChaudhriImelda BatesIan Roberts

Published in: PloS one (2020)

CRASH-2 is registered as ISRCTN86750102, ClinicalTrials.gov NCT00375258 and South African Clinical Trial Register DOH-27-0607-1919. WOMAN is registered as ISRCTN76912190, ClinicalTrials.gov NCT00872469, PACTR201007000192283, and EudraCT number 2008-008441-38.

Keyphrases

clinical trial
end stage renal disease
ejection fraction
newly diagnosed
spinal cord injury
chronic kidney disease
case report
prognostic factors
open label